11.91
전일 마감가:
$11.45
열려 있는:
$11.575
하루 거래량:
1.60M
Relative Volume:
1.19
시가총액:
$879.26M
수익:
$255.87M
순이익/손실:
$-103.27M
주가수익비율:
-8.4414
EPS:
-1.4109
순현금흐름:
$12.46M
1주 성능:
+4.57%
1개월 성능:
-4.80%
6개월 성능:
-38.70%
1년 성능:
-55.12%
슈뢰딩거 Stock (SDGR) Company Profile
명칭
Schrodinger Inc
전화
503-299-1150
주소
1540 BROADWAY, NEW YORK, NY
Compare SDGR vs VEEV, TEM, BTSG, HQY, WAY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
SDGR
Schrodinger Inc
|
11.91 | 839.39M | 255.87M | -103.27M | 12.46M | -1.4109 |
|
VEEV
Veeva Systems Inc
|
159.09 | 24.73B | 3.20B | 908.91M | 1.39B | 5.4168 |
|
TEM
Tempus Ai Inc
|
49.53 | 7.70B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
46.04 | 8.71B | 12.91B | 104.80M | 394.69M | 0.8769 |
|
HQY
Healthequity Inc
|
81.36 | 6.59B | 1.31B | 215.20M | 408.32M | 2.4627 |
|
WAY
Waystar Holding Corp
|
22.43 | 4.12B | 1.10B | 112.09M | 283.19M | 0.6096 |
슈뢰딩거 Stock (SDGR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-15 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2025-09-30 | 개시 | Goldman | Neutral |
| 2025-08-15 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-08-14 | 개시 | Barclays | Overweight |
| 2025-07-03 | 재개 | Morgan Stanley | Equal-Weight |
| 2024-07-02 | 개시 | Leerink Partners | Outperform |
| 2023-12-05 | 개시 | KeyBanc Capital Markets | Overweight |
| 2023-05-05 | 재개 | Piper Sandler | Overweight |
| 2022-12-19 | 개시 | Goldman | Neutral |
| 2022-03-01 | 개시 | Citigroup | Buy |
| 2021-11-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-19 | 개시 | Piper Sandler | Overweight |
| 2021-11-11 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2021-10-13 | 개시 | Berenberg | Buy |
| 2021-09-01 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-25 | 개시 | Craig Hallum | Buy |
| 2020-11-23 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-10-12 | 업그레이드 | Jefferies | Hold → Buy |
| 2020-03-02 | 개시 | BMO Capital Markets | Outperform |
| 2020-03-02 | 개시 | Jefferies | Hold |
| 2020-03-02 | 개시 | Morgan Stanley | Equal-Weight |
모두보기
슈뢰딩거 주식(SDGR)의 최신 뉴스
KeyBanc Maintains Schrodinger(SDGR.US) With Buy Rating, Cuts Target Price to $20 - Moomoo
Understanding Momentum Shifts in (SDGR) - Stock Traders Daily
If You Invested $1,000 in Schrodinger, Inc. (SDGR) - Stock Titan
Schrodinger (HAM:43Z) Cash Receipts from Deposits by Banks and Customers - GuruFocus
Schrodinger (HAM:43Z) Other Assets for Banks - GuruFocus
Schrodinger Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
Schrodinger Inc Stock Historical Valuations | HAM:43Z - GuruFocus
Schrodinger Inc Stock Intrinsic Values - GuruFocus
Schrodinger Inc (HAM:43Z) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Schrodinger Inc (HAM:43Z)Valuation Measures & Financial Statistics - GuruFocus
Schrodinger Inc (HAM:43Z) Stock News, Headlines & Updates - GuruFocus
Schrodinger Inc (HAM:43Z) Valuation: Possible Value Trap, Think Twice - GuruFocus
Schrodinger Inc Stock Warning Signs | HAM:43Z - GuruFocus
Who's Buying or Selling Schrodinger Inc (HAM:43Z) Stock Today? - GuruFocus
Schrodinger Inc (HAM:43Z) Competitors 2026 - GuruFocus
Schrodinger Inc (HAM:43Z) Stock HoldersInstitutional & Insider Ownership - GuruFocus
Schrodinger Inc (HAM:43Z) Stock Earnings Transcripts - GuruFocus
Schrodinger Inc Stock Operating Data - GuruFocus
Schrodinger Inc (HAM:43Z) Dividend - GuruFocus
Schrodinger Inc (HAM:43Z) Stock Price & 30 Year Financial Data - GuruFocus
Schrodinger Inc (HAM:43Z) DCF Valuation - GuruFocus
SDGR Stock Chart | SCHRODINGER INC (NASDAQ:SDGR) - ChartMill
Schrödinger, Inc. (43Z.F) Stock Price, News, Quote & History - Yahoo! Finance Canada
Schrodinger, Inc. (SDGR) Stock Forecasts - Yahoo Finance
SchröDinger: Transition Pressure And Competition Offset Ecosystem Strength (NASDAQ:SDGR) - Seeking Alpha
Avoiding Lag: Real-Time Signals in (SDGR) Movement - Stock Traders Daily
Schrodinger Inc Stock: Physics-Based Computing Leader in Drug Discovery and Materials Science for In - AD HOC NEWS
Schrodinger, Inc. (NASDAQ:SDGR) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Schrodinger (NASDAQ:SDGR) Sets New 52-Week LowTime to Sell? - MarketBeat
Vanguard disaggregates holdings; SDGR filing shows 0 shares (SDGR) - Stock Titan
Schrödinger Discontinues Clinical Program After Two Patient Deaths - MSN
Tudor Investment Corp ET AL Has $6.75 Million Position in Schrodinger, Inc. $SDGR - marketbeat.com
Transcript : Schrödinger, Inc. Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum, Mar-17-2026 09 - marketscreener.com
Schrodinger Conference: SDGR Targets Hosted Shift, Platform Adoption, EBITDA Profitability in 3 Years - Yahoo Finance
Discipline and Rules-Based Execution in SDGR Response - Stock Traders Daily
Schrödinger (SDGR) Morgan Stanley 22nd Annual Global Healthcare Conference Summary - Quartr
Schrodinger (SDGR) VP details stock, RSU and option holdings - Stock Titan
Schrodinger downgraded at Citi after clinical program exit - MSN
Schrödinger updates 2025 software growth guidance to 8%-13% amid pharma scale-up delays and operational efficiency focus - msn.com
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)March 18, 2026 - BioSpace
Schrodinger reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
SDGR: Analyst Michael Yee of UBS Lowers Price Target to $13, Mai - GuruFocus
UBS Group Cuts Schrodinger (NASDAQ:SDGR) Price Target to $13.00 - MarketBeat
Schrödinger at KeyBanc Forum: Strategic Shift to Hosted Contracts By Investing.com - Investing.com India
Schrödinger at KeyBanc Forum: Strategic Shift to Hosted Contracts - Investing.com
SDGR: Strategic shift to hosted software, AI integration, and new products drive growth and industry impact - TradingView
Schrodinger (SDGR) Upgraded to Buy by B of A Securities | SDGR S - GuruFocus
Farallon Capital Management LLC Lowers Holdings in Schrodinger, Inc. $SDGR - MarketBeat
Keybanc Maintains Schrödinger (SDGR) Overweight Recommendation - MSN
Schrödinger slides after early-stage trial data for cancer therapy - MSN
Schrödinger Promotes Therese Abrams to Principal Accounting Officer - The Globe and Mail
슈뢰딩거 (SDGR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):